The LeForte System includes orthopedic implants used in craniomaxillofacial procedures, such as trauma and reconstruction. Bacterin plans a beta-launch of the LeForte System in the United States and Canada next month with the full product release to occur during the second quarter of 2012.
As a result of the agreement, the company has promoted Nick Navarro to executive vice president of medical devices. Mr. Navarro has previous experience with Johnson & Johnson.
Related Articles on Orthopedic Devices:
Global Orthopedic Implant Market to Reach $46.5B by 2017
InVivo Therapeutics Reports $3M Net Income in 3Q
Alphatec Spine Names Frances Harrison to Vice President Position
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.